795TiP Phase III study of the programmed cell death protein 1 inhibitor PF-06801591 plus bacillus Calmette-Guérin for non-muscle invasive bladder cancer

Autor: Steinberg, G.D., Saltstein, D., Shore, N., Cesari, R., Vermette, J., Pierce, K., Blake-Haskins, J.A., Hariharan, S., Bedke, J., Powles, T.
Zdroj: In Annals of Oncology September 2020 31 Supplement 4:S604-S604
Databáze: ScienceDirect